Related Experiment Video
Updated: Jul 3, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Empty Versus Full Bladder Protocols in Radiotherapy Planning for Localised Prostate Cancer: A Dosimetric Study
Rebecca Louise Nield1,2, Sagar Ramani1,2, David Robert Harry Christie1,2,3
1GenesisCare, Southport, Queensland, Australia.
Empty bladder preparation for prostate radiotherapy planning is feasible, maintaining target coverage while reducing rectal dose. This approach may improve patient comfort and streamline workflows without compromising treatment efficacy.
Area of Science:
- Radiation Oncology
- Medical Physics
- Urology
Background:
- Full bladder preparation is standard for prostate radiotherapy, aiming to shield organs at risk.
- However, achieving consistent full bladder volumes is challenging and can extend treatment planning times.
Purpose of the Study:
- To evaluate the dosimetric and volumetric differences between full and empty bladder preparations for prostate radiotherapy planning.
- To assess the impact of bladder volume on target coverage and organ-at-risk sparing.
Main Methods:
- CT simulations were performed on 20 prostate cancer patients with both full and empty bladders.
- Volumetric Modulated Arc Therapy (VMAT) plans were generated for both conditions, prescribing 60Gy/20 fractions with a simultaneous integrated boost to 66Gy for dominant intraprostatic lesions.
- Key dosimetric endpoints, including bladder and rectal V30 and V60, and planning target volume (PTV) coverage, were compared using paired t-tests.
Main Results:
- Empty bladder volumes were significantly smaller than full bladder volumes (median 126.4 cm³ vs. 276.0 cm³).
- Clinical target volume (CTV) volumes and PTV coverage remained comparable between the two preparations.
- Rectal V30 was significantly reduced with empty bladder planning (15.6% vs. 19.9%), while bladder V30 increased (26.9% vs. 20.7%).
Conclusions:
- Empty bladder planning for prostate radiotherapy is a viable alternative that maintains target coverage and PTV dose.
- This method significantly reduces rectal dose and may improve patient comfort and workflow efficiency.
- The observed increase in bladder V30 is acceptable as other bladder dose constraints were met.
More Related Videos
09:49A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018